Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
10 mar 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research
InCoax
08 mar 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
Carlsquare
06 mar 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research
Zinzino
06 mar 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research
Risk Intelligence
01 mar 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research
Carlsquare
28 feb 2023
Research update ALM Equity: Write-downs in associates affect results
Equity Research
ALM Equity
28 feb 2023
First impressions Zinzino, Q4 2022: Again, profitability above our expectations
Equity Research
Zinzino
24 feb 2023
Research Update SBB i Norden Q4 2022: Better earnings outweigh lower NAV
Equity Research
SBB i Norden
23 feb 2023
First Impression SBB i Norden, Q4 2022: Better earnings capacity than expected
Equity Research
SBB i Norden
22 feb 2023
First impression Risk Intelligence, Q4 2022: Mixed outcome in comparison to our adjusted estimates
Equity Research
Risk Intelligence
22 feb 2023
First impression ALM Equity, Q4 2022: Asset write downs impact results
Equity Research
ALM Equity
22 feb 2023
Carlsquare weekly market letter: Better numbers push stocks lower, thanks to the Fed
Equity Research
Carlsquare
20 feb 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research
Abera Bioscience
20 feb 2023
Research Update Ecoclime Q4 2022: A very strong quarter for Evertherm
Equity Research
17 feb 2023
Update HANZA Q4 2022: Stars still aligned for expansion
Equity Research
Hanza
16 feb 2023
First Impression Ecoclime Q4 2022: Better than expected revenue growth
Equity Research
15 feb 2023
Carlsquare weekly market letter: Is SEK at a breakpoint and what does it imply for the stock market?
Equity Research
Carlsquare
14 feb 2023
First impression HANZA, Q4 2022: No slowdown
Equity Research
Hanza
10 feb 2023
Preview SBB, Q4 2022: Better valued after transactions
Equity Research
SBB i Norden
08 feb 2023
Mrkt BUZZ Adverty: Above resistance after strong report
Equity Research
1
…
25
26
27
28
29
…
64